Bulletin
Investor Alert

Alexion Pharmaceuticals Inc.

NAS: ALXN

GO
/marketstate/country/us

After Hours

 --Quotes are delayed by 20 min

Mar 5, 2021, 5:29 p.m.

/zigman2/quotes/206262068/composite

$

150.10

Change

0.00 0.00%

Volume

Volume 89,322

Quotes are delayed by 20 min

/zigman2/quotes/206262068/composite

Previous close

$ 148.46

$ 150.10

Change

+1.64 +1.10%

Day low

Day high

$148.18

$150.56

Open

52 week low

52 week high

$72.67

$162.60

Open

Deborah L. Dunsire

Currently, Deborah L. Dunsire is President & Chief Executive Officer at H. Lundbeck A. She is also Secretary for Biotechnology Innovation Organization and on the board of 6 other companies.

In her past career Dr. Dunsire held the position of President, Chief Executive Officer & Director at FORUM Pharmaceuticals, Inc., President, Chief Executive Officer & Director at XTuit Pharmaceuticals, Inc., Vice President-Oncology Business Unit at Novartis AG and Senior Vice President-North America Oncology at Novartis Oncology, Inc. (a subsidiary of Novartis AG) and Director at Takeda Pharmaceutical Co., Ltd. and President, Chief Executive Officer & Director at Millennium Pharmaceuticals, Inc. (a subsidiary of Takeda Pharmaceutical Co., Ltd.).

She received a graduate degree from the University of the Witwatersrand.

Transactions

Date Shares Transaction Value
05/14/2020 941   Award at $0 per share. 0
05/14/2020 3,468   Award at $0 per share. 0
05/15/2019 740   Award at $0 per share. 0
05/15/2019 2,726   Award at $0 per share. 0
05/09/2018 2,174   Award at $0 per share. 0
02/08/2018 2,085   Award at $0 per share. 0

Officers and Executives

Dr. Ludwig N. Hantson
Chief Executive Officer & Director
Dr. Aradhana Sarin
Chief Financial Officer & Executive Vice President
Mr. Brian M. Goff
Chief Commercial, Global Operations Officer & EVP
Mr. George Llado
Chief Information Officer & Senior Vice President
Dr. John J. Orloff
Executive VP, Head-Research & Development
Dr. Tanisha V. Cariño
Chief Corporate Affairs Officer & EVP
Dr. Gianluca Pirozzi
Head-Clinical Development, Hematology & Nephrology
Mr. Uzair Qadeer
Chief Diversity Officer
Ms. Becky Lillie
Chief Human Experience Officer
Ms. Tamar Thompson
Vice President-US Government Affairs & Policy
Ms. Indrani M. Franchini
Chief Compliance Officer & Executive VP
Ms. Rana Strellis
SVP-Global Culture & Social Responsibility
Mr. Daniel A. Bazarko
Chief Accounting Officer & Senior Vice President
Mr. Christopher J. Stevo
Head-Investor Relations1
Ms. Morgan Sanford
Chief of Staff
Ms. Ellen V. Chiniara
Secretary, Chief Legal Officer & Executive VP
Mr. David Richard Brennan
Chairman
Dr. Andreas Rummelt
Independent Director
Mr. John T. Mollen
Independent Director
Mr. Christopher J. Coughlin
Independent Director
Dr. Paul A. Friedman
Independent Director
Dr. Francois Nader
Independent Director
Dr. Deborah L. Dunsire
Independent Director
Ms. Judith A. Reinsdorf
Independent Director
Trending Tickers
  • /quotes/zigman/17636479/composite VUZI+15.60%
  • /quotes/zigman/237947/composite JCP-5.83%
  • /quotes/zigman/59392505/composite NUGT-2.93%
  • /quotes/zigman/59386294/composite JNUG-5.94%
  • /quotes/zigman/65801738/composite TLT+1.11%
X
Powered by StockTwits
Link to MarketWatch's Slice.